CELCUITY INC. Interest Expense on Debt
CELCUITY INC. (CELC) reported Interest Expense on Debt of $3.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-08-13
- CELCUITY INC. interest expense, debt for the quarter ending 2026-06-30 was $3.50M, a 9.38% increase year-over-year.
- CELCUITY INC. interest expense, debt for the quarter ending 2026-03-31 was $4.50M, a 40.63% increase year-over-year.
- CELCUITY INC. interest expense, debt for the quarter ending 2025-06-30 was $3.20M.
- CELCUITY INC. interest expense, debt for the quarter ending 2025-03-31 was $3.20M.
- CELCUITY INC. interest expense, debt for fiscal 2025 was $14.40M, a 39.81% increase from fiscal 2024.
- CELCUITY INC. interest expense, debt for fiscal 2024 was $10.30M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 12 month |
|---|---|---|---|
| 2026-06-30 | $3.50M 10-Q · filed 2026-08-13 | $7.90M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.50M 10-Q · filed 2026-05-14 | ||
| 2025-12-31 | $14.40M 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $3.20M 10-Q · filed 2026-08-13 | $6.40M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $3.20M 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $10.30M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |